Literature DB >> 7000782

ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products.

B G Van Ness, J B Howard, J W Bodley.   

Abstract

We have isolated the novel amino acid, amino acid X, in elongation factor 2 (EF-2) which is ADP-ribosylated by diphtheria toxin (Robinson, E. A., Hendriksen, O., and Maxwell, E. S. (1974) J. Biol. Chem. 249, 5088-5093). The pure ribosyl-amino acid was obtained in milligram quantities following sequential enzymatic degradation of yeast ADP-ribosyl-EF-2 (Van Ness, B. G., Howard, J. B., and Bodley, J. W. (1978) J. Biol. Chem. 253, 8687-8690) with an overall yield of 30 to 60%. In the course of acid hydrolysis, the ribosyl-amino acid was converted first to an intermediate compound which did not contain ribose. Further acid hydrolysis converted the intermediate to amino acid X and ammonia. Alkaline hydrolysis of the ribosyl-amino acid produced a different intermediate which contained ribose. We have isolated the two hydrolysis intermediates and on the basis of the properties of all four compounds we conclude that the ribosyl-amino acid contains an amido function which is not involved in a glycosidic linkage and a net positive charge of 2 at acid pH. We believe that the amino acid amide occurs in EF-2 and for this compound we propose the trivial name diphthamide. Acid hydrolysis of diphthamide yields amino acid X for which we propose the trivial name diphthine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000782

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Clin Cancer Res       Date:  2011-10-15       Impact factor: 12.531

2.  Reconstitution of diphthine synthase activity in vitro.

Authors:  Xuling Zhu; Jungwoo Kim; Xiaoyang Su; Hening Lin
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

3.  Noncanonical Radical SAM Enzyme Chemistry Learned from Diphthamide Biosynthesis.

Authors:  Min Dong; Yugang Zhang; Hening Lin
Journal:  Biochemistry       Date:  2018-05-10       Impact factor: 3.162

Review 4.  Novel bacterial ADP-ribosylating toxins: structure and function.

Authors:  Nathan C Simon; Klaus Aktories; Joseph T Barbieri
Journal:  Nat Rev Microbiol       Date:  2014-07-14       Impact factor: 60.633

5.  Chemogenomic approach identified yeast YLR143W as diphthamide synthetase.

Authors:  Xiaoyang Su; Zhewang Lin; Wei Chen; Hong Jiang; Sheng Zhang; Hening Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 6.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

7.  A chemical genomic screen in Saccharomyces cerevisiae reveals a role for diphthamidation of translation elongation factor 2 in inhibition of protein synthesis by sordarin.

Authors:  Javier Botet; María Rodríguez-Mateos; Juan P G Ballesta; José Luis Revuelta; Miguel Remacha
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

8.  Characterization of a Chinese hamster ovary cell mutant having a mutation in elongation factor-2.

Authors:  Pradeep K Gupta; Shihui Liu; Stephen H Leppla
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

9.  A structural domain mediates attachment of ethanolamine phosphoglycerol to eukaryotic elongation factor 1A in Trypanosoma brucei.

Authors:  Eva Greganova; Manfred Heller; Peter Bütikofer
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

10.  A type VI secretion system effector protein, VgrG1, from Aeromonas hydrophila that induces host cell toxicity by ADP ribosylation of actin.

Authors:  G Suarez; J C Sierra; T E Erova; J Sha; A J Horneman; A K Chopra
Journal:  J Bacteriol       Date:  2010-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.